Genrix (Shanghai) Biopharmaceutical
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (22)
A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma
Started: 3/9/2026
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Started: 8/15/2025
A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
Started: 9/3/2024
A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps
Started: 9/19/2024
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
Started: 9/25/2025
Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis
Started: 6/13/2022
GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma
Started: 8/26/2024
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).
Started: 3/24/2024
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
Started: 2/8/2023
to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis
Started: 9/7/2020
A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult
Started: 9/18/2025
A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers.
Started: 10/10/2025
Phase I Trial of GR1803 Injection in Patients With RRMM
Started: 5/27/2022
A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma
Started: 8/31/2025
Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE
Started: 3/8/2022
The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers
Started: 6/16/2023
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults
Started: 3/4/2023
A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo
Started: 6/1/2026
A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Participants in China.
Started: 6/1/2026